Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Manual Rainin Liquidator 96 Pipette Streamlines Genotyping

Published: Wednesday, January 23, 2013
Last Updated: Wednesday, January 23, 2013
Bookmark and Share
METTLER TOLEDO announce Affymetrix Research Services Lab is using the Rainin Liquidator 96 manual bench-scale pipetting system to augment its high-throughput genotyping services.

The Liquidator 96 allows Affymetrix to process 96-well sample plates quickly and precisely in support of its clients’ large-scale, microarray-based genotype studies. The technology is saving its lab an average of 30-45 minutes per every two prepared PCR plates.

“We use Rainin’s Liquidator 96 for high-throughput applications in many areas. Its versatility allowed us to replace lower capacity pipettes in PCR, purification and hybridization processes,” noted Kay Mekaru, Scientific Services Lab Supervisor, Affymetrix. The Liquidator 96 in fact has helped Affymetrix develop a complete protocol for running fast, high-quality whole-genome assays to provide enlightening insight into an organism’s gene expression profile.

The Liquidator 96 helps Affymetrix maintain the strict adherence to protocol required for success when working with whole genomes, allowing the company to expertly manage plate preparation, add master mix, and dilute, distribute and pool samples.

To learn more about how Affymetrix has saved time and streamlined processes using the Rainin Liquidator 96, download the case study, as well as Affymetrix’s PCR plate set-up method, at www.mt.com/Liq96-ARSL.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

The Art of Pipetting
Sculptor and installation artist Mitra Fabian has created an iceberg sculpture made from recycled pipette tips.
Friday, February 05, 2016
Scientific News
Potential “Good Fat” Biomarker
New method to measure the activity of energy consuming brown fat cells could ease the testing weight loss drugs.
MicroRNA Pathway Could Lead to New Avenues for Leukemia Treatment
Cancer researchers at the University of Cincinnati have found a particular signaling route in microRNA (miR-22) that could lead to targets for acute myeloid leukemia, the most common type of fast-growing cancer of the blood and bone marrow.
Soy Shows Promise as Natural Anti-Microbial Agent
Soy isoflavones and peptides may inhibit the growth of microbial pathogens that cause food-borne illnesses, according to a new study from University of Guelph researchers.
Doubling Down on Dengue
HMS researchers have discovered two ways a compound blocks dengue virus.
Soy Shows Promise as Natural Anti-Microbial Agent
Researchers from University of Guelph show that soy isoflavones and peptides could be used to reduce microbial contamination of food.
AstraZeneca to Sequence 2 Million Genomes in Search for New Drugs
Company launches integrated genomics approach which aims to transform drug discovery and development.
Unique Model for Studying ALS
Unique mouse model will allow researchers to better study the genetic origins and potential treatments of ALS.
Targeting an ‘Undruggable’ Cancer Gene
RAS genes are mutated in more than 30 percent of human cancers and represent one of the most sought-after cancer targets for drug developers.
Biomarkers for Profiling Prostate Cancer Patients
Exiqon A/S has announced the publication of validation of prognostic microRNA biomarkers for the aggressiveness of prostate cancer in independent cohorts.
Improving Engineered T-Cell Cancer Treatment
Purdue University researchers may have figured out a way to call off a cancer cell assassin that sometimes goes rogue and assign it a larger tumor-specific "hit list."
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!